Letters to HCPs

Important information for Healthcare Professionals

Beovu ▼ (brolucizumab) – Dear Healthcare Professional Communication

DHPC describing the updated recommendations to minimise the known risk of intraocular inflammation, including retinal vasculitis and/or retinal vascular occlusion.

For Healthcare Professionals